Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:15 pm Unchanged | 2023-12-31 | 13G | Marpai, Inc. MRAI | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 5:10 pm Purchase | 2023-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LLC | 8,027,593 6.200% | 1,529,675 (+23.54%) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 194,100 4.990% | 0 (Unchanged) | Filing History |
| 2024-02-13 3:27 pm Sale | 2023-12-31 | 13G | Alimera Sciences, Inc. ALIM | Altium Capital Management LLC | 2,660,000 5.000% | -324,803 (-10.88%) | Filing History |
| 2024-02-02 6:09 pm Purchase | 2024-01-29 | 13G | Skye Bioscience, Inc. SKYE | Altium Capital Management LLC | 1,301,518 5.400% | 1,301,518 (New Position) | Filing History |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 194,100 8.000% | 194,100 (New Position) | Filing History |
| 2023-11-22 5:31 pm Purchase | 2023-11-16 | 13G | Volcon, Inc. VLCN | Altium Capital Management LLC | 78 9.900% | 78 (New Position) | Filing History |
| 2023-08-23 06:01 am Purchase | 2023-08-15 | 13G | Alimera Sciences, Inc. ALIM | Altium Capital Management LLC | 2,984,803 5.700% | 2,984,803 (New Position) | Filing History |
| 2023-05-02 8:23 pm Purchase | 2023-04-24 | 13G | GRI Bio, Inc. GRI | Altium Capital Management LLC | 820 9.990% | 820 (New Position) | Filing History |
| 2023-04-26 5:18 pm Purchase | 2023-04-17 | 13G | Marpai, Inc. MRAI | Altium Capital Management LLC | 451,332 6.200% | 451,332 (New Position) | Filing History |
| 2023-02-14 4:51 pm Unchanged | 2022-12-31 | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LLC | 6,497,918 5.700% | 0 (Unchanged) | Filing History |
| 2023-02-14 3:59 pm Unchanged | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LLC | 1,355,372 4.950% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:44 pm Sale | 2022-12-31 | 13G | HyreCar Inc. HYREQ | Altium Capital Management LLC | 1,688,120 5.600% | -48,795 (-2.81%) | Filing History |
| 2023-02-14 2:35 pm Unchanged | 2022-12-31 | 13G | Sadot Group Inc. SDOT | Altium Capital Management LLC | 288,809 4.990% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:35 pm Sale | 2022-12-31 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LLC | 0 0.000% | -41,667 (Position Closed) | Filing History |
| 2023-02-14 12:26 pm Unchanged | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-12-21 2:12 pm Purchase | 2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LLC | 1,355,372 5.200% | 1,355,372 (New Position) | Filing History |
| 2022-11-17 5:08 pm Purchase | 2022-11-04 | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LLC | 41,667 7.700% | 41,667 (New Position) | Filing History |
| 2022-11-08 7:44 pm Purchase | 2022-09-02 | 13G | HyreCar Inc. HYREQ | Altium Capital Management LLC | 1,736,915 5.800% | 1,736,915 (New Position) | Filing History |
| 2022-02-14 3:09 pm Sale | 2022-02-02 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 4,467 9.990% | -859 (-16.13%) | Filing History |